drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous Graph

BACKGROUND: For translational impact, both accurate drug response prediction and biological plausibility of predictive features are needed. We present drGT, a heterogeneous graph deep learning model over drugs, genes, and cell lines that couples prediction with mechanism-oriented interpretability via attention coefficients (ACs). RESULTS: We assess both predictive generalization (random, unseen-drug, unseen-cell, and zero-shot splits) and biological plausibility (use of text-mined PubMed gene-drug co-mentions and comparison to a structure-based DTI predictor) on GDSC, NCI60, and CTRP datasets. Across benchmarks, drGT consistently delivers top regression performance while maintaining competitive classification accuracy for drug sensitivity. Under random 5-fold cross-validation, drGT attains an AUROC of up to 0.945 (3rd overall) and an [Formula: see text] up to 0.690, outperforming all baselines on regression. In leave-one-out tests for unseen cell lines and drugs, drGT achieves AUROCs of 0.706 and 0.844, and [Formula: see text] values of 0.692 and 0.022, the only model yielding positive [Formula: see text] for unseen drugs. In zero-shot prediction, drGT achieves an AUROC of 0.786 and a regression [Formula: see text] of 0.334, both representing the highest scores among all models. For interpretability, AC-derived drug-gene links recover known biology: among 976 drugs with known DTIs, 36.9% of predicted links match established DTIs, and 63.7% are supported by either PubMed abstracts or a structure-based predictive model. Enrichment analyses of AC-prioritized genes reveal drug-perturbed biological processes, providing pathway-level explanations. CONCLUSIONS: drGT advances predictive generalization and mechanism-centered interpretability, offering state-of-the-art regression accuracy and literature-supported biological hypotheses that demonstrate the use of graph learning from heterogeneous input data for biological discovery. Code: https://github.com/sciluna/drGT.

Authors

Institutions

Publication Details

Journal
BMC Bioinformatics
Published
2026-06-16
DOI
https://doi.org/10.1186/s12859-026-06417-z
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous Graph

Augustin Luna, H C Lee, Yoshitaka Inoue, Rui Kuang et al.
BMC Bioinformatics
Computational Drug Discovery Methods
article

drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous Graph

Augustin Luna, H C Lee, Yoshitaka Inoue, Rui Kuang, Tianfan Fu
article en

Abstract

BACKGROUND: For translational impact, both accurate drug response prediction and biological plausibility of predictive features are needed. We present drGT, a heterogeneous graph deep learning model over drugs, genes, and cell lines that couples prediction with mechanism-oriented interpretability via attention coefficients (ACs). RESULTS: We assess both predictive generalization (random, unseen-drug, unseen-cell, and zero-shot splits) and biological plausibility (use of text-mined PubMed gene-drug co-mentions and comparison to a structure-based DTI predictor) on GDSC, NCI60, and CTRP datasets. Across benchmarks, drGT consistently delivers top regression performance while maintaining competitive classification accuracy for drug sensitivity. Under random 5-fold cross-validation, drGT attains an AUROC of up to 0.945 (3rd overall) and an [Formula: see text] up to 0.690, outperforming all baselines on regression. In leave-one-out tests for unseen cell lines and drugs, drGT achieves AUROCs of 0.706 and 0.844, and [Formula: see text] values of 0.692 and 0.022, the only model yielding positive [Formula: see text] for unseen drugs. In zero-shot prediction, drGT achieves an AUROC of 0.786 and a regression [Formula: see text] of 0.334, both representing the highest scores among all models. For interpretability, AC-derived drug-gene links recover known biology: among 976 drugs with known DTIs, 36.9% of predicted links match established DTIs, and 63.7% are supported by either PubMed abstracts or a structure-based predictive model. Enrichment analyses of AC-prioritized genes reveal drug-perturbed biological processes, providing pathway-level explanations. CONCLUSIONS: drGT advances predictive generalization and mechanism-centered interpretability, offering state-of-the-art regression accuracy and literature-supported biological hypotheses that demonstrate the use of graph learning from heterogeneous input data for biological discovery. Code: https://github.com/sciluna/drGT.

BMC Bioinformatics
University of Minnesota (US), Hankou University (CN), United States National Library of Medicine (US), National Cancer Institute (US)
U.S. National Library of Medicine
Quality Education
Openalex Percentile: Top 5%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.